CTR20261524 clinical trial report covering Peturadol, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07539259 clinical trial report covering Spironolactone, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07541001 clinical trial report covering PRL3-zumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07542158 clinical trial report covering FLUORODOPA F-18, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600123044 clinical trial report covering Flunotinib maleate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07542262 clinical trial report covering Nivolumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07541430 clinical trial report covering ES-014, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600123039 clinical trial report covering Tislelizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07543120 clinical trial report covering BW-00163, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07541287 clinical trial report covering JADE-001, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07543172 clinical trial report covering Adagrasib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07544784 clinical trial report covering Cadonilimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.